Evaluating the optimal activated clotting time during carotid artery stenting

Am J Cardiol. 2006 Jun 1;97(11):1657-60. doi: 10.1016/j.amjcard.2005.12.062. Epub 2006 Apr 19.

Abstract

Carotid artery stenting is an alternative to carotid endarterectomy for patients at high risk for surgery for carotid artery stenosis. Although unfractionated heparin is routinely used, there are no published data evaluating the optimal activated clotting time during carotid stenting. In a retrospective analysis of 605 patients who underwent carotid stenting using unfractionated heparin at the Cleveland Clinic Foundation, the optimal peak procedural activated clotting time associated with the lowest combined incidence of death, stroke, or myocardial infarction was 250 to 299 seconds.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Aged
  • Blood Coagulation / drug effects
  • Blood Coagulation / physiology*
  • Blood Vessel Prosthesis Implantation / instrumentation*
  • Carotid Stenosis / blood*
  • Carotid Stenosis / drug therapy
  • Carotid Stenosis / mortality
  • Carotid Stenosis / surgery
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Follow-Up Studies
  • Heparin / therapeutic use
  • Humans
  • Male
  • Monitoring, Intraoperative
  • Retrospective Studies
  • Stents*
  • Survival Rate
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Heparin